{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:47:29Z","timestamp":1794484049145,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer is a multifactorial disease and virus-mediated carcinogenesis is one of the crucial factors, which is poorly understood. Human cytomegalovirus (HCMV) is a herpesvirus and its components have been evidenced to be associated with cancer of different tissue origin. However, its role in cancer remains unknown. Here, we identified a conserved herpesviral tegument protein known as pUL48 of HCMV, encoding deubiquitinase enzyme, as having a key role in carcinogenesis. We show using deubiquitinase sufficient- and deficient-HCMV that HCMV deubiquitinase is a key in inducing enhanced cellular metabolic activity through upregulation of several anti-apoptotic genes and downregulation of several pro-apoptotic genes expression. Furthermore, HCMV deubiquitinase acquires pro-tumor functions by inhibiting PRR-mediated type I interferon via deubiquitination of TRAF6, TRAF3, IRAK1, IRF7 and STING. Taken together, our results suggest that HCMV infection may promote oncogenesis by inhibiting innate immunity of the host.<\/jats:p>","DOI":"10.1038\/cddis.2017.461","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T12:43:29Z","timestamp":1507207409000},"page":"e3078-e3078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways"],"prefix":"10.1038","volume":"8","author":[{"given":"Puja","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachimuthu Senthil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafullakumar","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"BFcddis2017461_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","volume":"1782","author":"ME McLaughlin-Drubin","year":"2008","unstructured":"McLaughlin-Drubin ME, Munger K . Viruses associated with human cancer. Biochim Biophys Acta 2008; 1782: 127\u2013150.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2017461_CR2","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/v6104047","volume":"6","author":"A Morales-Sanchez","year":"2014","unstructured":"Morales-Sanchez A, Fuentes-Panana EM . Human viruses and cancer. Viruses 2014; 6: 4047\u20134079.","journal-title":"Viruses"},{"key":"BFcddis2017461_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fonc.2014.00338","volume":"4","author":"D Landi","year":"2014","unstructured":"Landi D, Hegde M, Ahmed N . Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy. Front Oncol 2014; 4: 338.","journal-title":"Front Oncol"},{"key":"BFcddis2017461_CR4","doi-asserted-by":"crossref","first-page":"e56795","DOI":"10.1371\/journal.pone.0056795","volume":"8","author":"C Taher","year":"2013","unstructured":"Taher C, de Boniface J, Mohammad AA, Religa P, Hartman J, Yaiw KC et al. High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PloS ONE 2013; 8: e56795.","journal-title":"PloS ONE"},{"key":"BFcddis2017461_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2014.00230","volume":"4","author":"G Herbein","year":"2014","unstructured":"Herbein G, Kumar A . The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol 2014; 4: 230.","journal-title":"Front Oncol"},{"key":"BFcddis2017461_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.81178","volume":"11","author":"M Michaelis","year":"2009","unstructured":"Michaelis M, Doerr HW, Cinatl J . The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 2009; 11: 1\u20139.","journal-title":"Neoplasia"},{"key":"BFcddis2017461_CR7","first-page":"397","volume":"325","author":"DN Streblow","year":"2008","unstructured":"Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA . Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 2008; 325: 397\u2013415.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFcddis2017461_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/jir.2007.0183","volume":"27","author":"S Ogasawara","year":"2007","unstructured":"Ogasawara S, Yano H, Momosaki S, Akiba J, Nishida N, Kojiro S et al. Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo. J Interferon Cytokine Res 2007; 27: 507\u2013516.","journal-title":"J Interferon Cytokine Res"},{"key":"BFcddis2017461_CR9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.510290624","volume":"29","author":"H Yano","year":"1999","unstructured":"Yano H, Iemura A, Haramaki M, Ogasawara S, Takayama A, Akiba J et al. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 1999; 29: 1708\u20131717.","journal-title":"Hepatology"},{"key":"BFcddis2017461_CR10","doi-asserted-by":"crossref","first-page":"e1758","DOI":"10.1038\/cddis.2015.122","volume":"6","author":"S Kumar","year":"2015","unstructured":"Kumar S, Ingle H, Mishra S, Mahla RS, Kumar A, Kawai T et al. IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity. Cell Death Dis 2015; 6: e1758.","journal-title":"Cell Death Dis"},{"key":"BFcddis2017461_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G . Type I interferons in anticancer immunity. Nat Rev Immunol 2015; 15: 405\u2013414.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis2017461_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","volume":"147","author":"P D'Arcy","year":"2015","unstructured":"D'Arcy P, Wang X, Linder S . Deubiquitinase inhibition as a cancer therapeutic strategy. Pharmacol Ther 2015; 147: 32\u201354.","journal-title":"Pharmacol Ther"},{"key":"BFcddis2017461_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/embr.201338025","volume":"15","author":"J Zinngrebe","year":"2014","unstructured":"Zinngrebe J, Montinaro A, Peltzer N, Walczak H . Ubiquitin in the immune system. EMBO Rep 2014; 15: 28\u201345.","journal-title":"EMBO Rep"},{"key":"BFcddis2017461_CR14","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1101\/gad.1984410","volume":"24","author":"J Yuan","year":"2010","unstructured":"Yuan J, Kroemer G . Alternative cell death mechanisms in development and beyond. Genes Dev 2010; 24: 2592\u20132602.","journal-title":"Genes Dev"},{"key":"BFcddis2017461_CR15","doi-asserted-by":"crossref","first-page":"20025","DOI":"10.1073\/pnas.0706295104","volume":"104","author":"K Jarosinski","year":"2007","unstructured":"Jarosinski K, Kattenhorn L, Kaufer B, Ploegh H, Osterrieder N . A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc Natl Acad Sci USA 2007; 104: 20025\u201320030.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017461_CR16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.critrevonc.2016.04.018","volume":"103","author":"N Singh","year":"2016","unstructured":"Singh N, Singh AB . Deubiquitinases and cancer: a snapshot. Crit Rev Oncol Hematol 2016; 103: 22\u201326.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFcddis2017461_CR17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","volume":"31","author":"JM Fraile","year":"2012","unstructured":"Fraile JM, Quesada V, Rodriguez D, Freije JM, Lopez-Otin C . Deubiquitinases in cancer: new functions and therapeutic options. Oncogene 2012; 31: 2373\u20132388.","journal-title":"Oncogene"},{"key":"BFcddis2017461_CR18","doi-asserted-by":"crossref","first-page":"e15891","DOI":"10.1371\/journal.pone.0015891","volume":"6","author":"C Luise","year":"2011","unstructured":"Luise C, Capra M, Donzelli M, Mazzarol G, Jodice MG, Nuciforo P et al. An atlas of altered expression of deubiquitinating enzymes in human cancer. PloS ONE 2011; 6: e15891.","journal-title":"PloS ONE"},{"key":"BFcddis2017461_CR19","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1128\/JVI.00401-06","volume":"80","author":"J Wang","year":"2006","unstructured":"Wang J, Loveland AN, Kattenhorn LM, Ploegh HL, Gibson W . High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its active-site cysteine or histidine are viable. J Virol 2006; 80: 6003\u20136012.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR20","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1128\/JVI.00411-09","volume":"83","author":"ET Kim","year":"2009","unstructured":"Kim ET, Oh SE, Lee YO, Gibson W, Ahn JH . Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells. J Virol 2009; 83: 12046\u201312056.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E . The metabolism of tumors in the body. J Gen Physiol 1927; 8: 519\u2013530.","journal-title":"J Gen Physiol"},{"key":"BFcddis2017461_CR22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","volume":"424","author":"A Takaoka","year":"2003","unstructured":"Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003; 424: 516\u2013523.","journal-title":"Nature"},{"key":"BFcddis2017461_CR23","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1073\/pnas.89.14.6599","volume":"89","author":"R Kumar","year":"1992","unstructured":"Kumar R, Atlas I . Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proc Natl Acad Sci USA 1992; 89: 6599\u20136603.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017461_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0166-3542(94)90040-X","volume":"23","author":"I Arany","year":"1994","unstructured":"Arany I, Rady P, Tyring SK . Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1\/IFN beta cytokine pathway. Antiviral Res 1994; 23: 131\u2013141.","journal-title":"Antiviral Res"},{"key":"BFcddis2017461_CR25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2005.07.020","volume":"44","author":"C Liedtke","year":"2006","unstructured":"Liedtke C, Groger N, Manns MP, Trautwein C . Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J Hepatol 2006; 44: 342\u2013349.","journal-title":"J Hepatol"},{"key":"BFcddis2017461_CR26","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1038\/onc.2015.22","volume":"34","author":"E Lau","year":"2015","unstructured":"Lau E, Sedy J, Sander C, Shaw MA, Feng Y, Scortegagna M et al. Transcriptional repression of IFNbeta1 by ATF2 confers melanoma resistance to therapy. Oncogene 2015; 34: 5739\u20135748.","journal-title":"Oncogene"},{"key":"BFcddis2017461_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/08977190701345515","volume":"25","author":"SB Karauzum","year":"2007","unstructured":"Karauzum SB, Yasar D, Dirice E, Imir N, Luleci G, Ozes ON . Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas. Growth Factors 2007; 25: 94\u2013100.","journal-title":"Growth Factors"},{"key":"BFcddis2017461_CR28","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.4049\/jimmunol.179.11.7767","volume":"179","author":"S Varani","year":"2007","unstructured":"Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 2007; 179: 7767\u20137776.","journal-title":"J Immunol"},{"key":"BFcddis2017461_CR29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12985-017-0730-8","volume":"14","author":"W Wujcicka","year":"2017","unstructured":"Wujcicka W, Paradowska E, Studzinska M, Wilczynski J, Nowakowska D . Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women. Virol J 2017; 14: 64.","journal-title":"Virol J"},{"key":"BFcddis2017461_CR30","doi-asserted-by":"crossref","first-page":"e0154100","DOI":"10.1371\/journal.pone.0154100","volume":"11","author":"E Paradowska","year":"2016","unstructured":"Paradowska E, Jabo\u0144ska A, Studzi\u0144ska M, Skowro\u0144ska K, Suski P, Wi\u015bniewska-Ligier M et al. TLR9 -1486T\/C and 2848C\/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants. PloS ONE 2016; 11: e0154100.","journal-title":"PloS ONE"},{"key":"BFcddis2017461_CR31","doi-asserted-by":"crossref","first-page":"e1005546","DOI":"10.1371\/journal.ppat.1005546","volume":"12","author":"J Paijo","year":"2016","unstructured":"Paijo J, D\u00f6ring M, Spanier J, Grabski E, Nooruzzaman M, Schmidt T et al. cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells. PLoS Pathog 2016; 12: e1005546.","journal-title":"PLoS Pathog"},{"key":"BFcddis2017461_CR32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/JVI.01748-09","volume":"84","author":"VR DeFilippis","year":"2010","unstructured":"DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Fruh K . Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol 2010; 84: 585\u2013598.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/intimm\/dxf089","volume":"14","author":"K Hoshino","year":"2002","unstructured":"Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S . Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 2002; 14: 1225\u20131231.","journal-title":"Int Immunol"},{"key":"BFcddis2017461_CR34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ . Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339: 786\u2013791.","journal-title":"Science"},{"key":"BFcddis2017461_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni.2491","volume":"14","author":"DL Burdette","year":"2013","unstructured":"Burdette DL, Vance RE . STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 2013; 14: 19\u201326.","journal-title":"Nat Immunol"},{"key":"BFcddis2017461_CR36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/bbrc.1994.1479","volume":"200","author":"K Zhang","year":"1994","unstructured":"Zhang K, Kumar R . Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells. Biochem Biophys Res Commun 1994; 200: 522\u2013528.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2017461_CR37","first-page":"599","volume":"13","author":"PK Vadiveloo","year":"1996","unstructured":"Vadiveloo PK, Vairo G, Novak U, Royston AK, Whitty G, Filonzi EL et al. Differential regulation of cell cycle machinery by various antiproliferative agents is linked to macrophage arrest at distinct G1 checkpoints. Oncogene 1996; 13: 599\u2013608.","journal-title":"Oncogene"},{"key":"BFcddis2017461_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<19::AID-MRD4>3.0.CO;2-U","volume":"46","author":"JA Hamilton","year":"1997","unstructured":"Hamilton JA . CSF-1 and cell cycle control in macrophages. Mol Reprod Dev 1997; 46: 19\u201323.","journal-title":"Mol Reprod Dev"},{"key":"BFcddis2017461_CR39","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.onc.1201745","volume":"16","author":"M Matsuoka","year":"1998","unstructured":"Matsuoka M, Tani K, Asano S . Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages. Oncogene 1998; 16: 2075\u20132086.","journal-title":"Oncogene"},{"key":"BFcddis2017461_CR40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6690413","volume":"80","author":"WC Hung","year":"1999","unstructured":"Hung WC, Chuang LY . Sodium butyrate enhances STAT 1 expression in PLC\/PRF\/5 hepatoma cells and augments their responsiveness to interferon-alpha. Br J Cancer 1999; 80: 705\u2013710.","journal-title":"Br J Cancer"},{"key":"BFcddis2017461_CR41","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1158\/0008-5472.CAN-06-3564","volume":"67","author":"A Kroger","year":"2007","unstructured":"Kroger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J et al. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1. Cancer Res 2007; 67: 2972\u20132981.","journal-title":"Cancer Res"},{"key":"BFcddis2017461_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-8722-1-25","volume":"1","author":"P Pyo","year":"2008","unstructured":"Pyo P, Louie B, Rajamahanty S, Choudhury M, Konno S . Possible immunotherapeutic potentiation with D-fraction in prostate cancer cells. J Hematol Oncol 2008; 1: 25.","journal-title":"J Hematol Oncol"},{"key":"BFcddis2017461_CR43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/bjc.2013.422","volume":"109","author":"C Xie","year":"2013","unstructured":"Xie C, Xie DY, Lin BL, Zhang GL, Wang PP, Peng L et al. Interferon-beta gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT\/FOXO3a pathway. Br J Cancer 2013; 109: 1198\u20131205.","journal-title":"Br J Cancer"},{"key":"BFcddis2017461_CR44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.18632\/genesandcancer.37","volume":"5","author":"MS Park","year":"2014","unstructured":"Park MS, Kim BR, Kang S, Kim DY, Rho SB . The antihypertension drug doxazosin suppresses JAK\/STATs phosphorylation and enhances the effects of IFN-alpha\/gamma-induced apoptosis. Genes Cancer 2014; 5: 470\u2013479.","journal-title":"Genes Cancer"},{"key":"BFcddis2017461_CR45","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.3892\/mmr.2015.4230","volume":"12","author":"S Chen","year":"2015","unstructured":"Chen S, Liang L, Wang Y, Diao J, Zhao C, Chen G et al. Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-alpha2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo. Mol Med Rep 2015; 12: 6727\u20136737.","journal-title":"Mol Med Rep"},{"key":"BFcddis2017461_CR46","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1128\/JVI.03558-12","volume":"87","author":"I Brock","year":"2013","unstructured":"Brock I, Kruger M, Mertens T, von Einem J . Nuclear targeting of human cytomegalovirus large tegument protein pUL48 is essential for viral growth. J Virol 2013; 87: 6005\u20136019.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR47","doi-asserted-by":"crossref","first-page":"47221","DOI":"10.18632\/oncotarget.9722","volume":"7","author":"H Costa","year":"2016","unstructured":"Costa H, Xu X, Overbeek G, Vasaikar S, Patro CP, Kostopoulou ON et al. Human cytomegalovirus may promote tumour progression by upregulating arginase-2. Oncotarget 2016; 7: 47221\u201347231.","journal-title":"Oncotarget"},{"key":"BFcddis2017461_CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/carcin\/bgt292","volume":"35","author":"Z Khan","year":"2014","unstructured":"Khan Z, Yaiw KC, Wilhelmi V, Lam H, Rahbar A, Stragliotto G et al. Human cytomegalovirus immediate early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis. Carcinogenesis 2014; 35: 145\u2013154.","journal-title":"Carcinogenesis"},{"key":"BFcddis2017461_CR49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1348-0421.2003.tb03470.x","volume":"47","author":"J Kim","year":"2003","unstructured":"Kim J, Kwon YJ, Park ES, Sung B, Kim JH, Park CG et al. Human cytomegalovirus (HCMV) IE1 plays role in resistance to apoptosis with etoposide in cancer cell line by Cdk2 accumulation. Microbiol Immunol 2003; 47: 959\u2013967.","journal-title":"Microbiol Immunol"},{"key":"BFcddis2017461_CR50","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.1310779111","volume":"111","author":"Y Yu","year":"2014","unstructured":"Yu Y, Maguire TG, Alwine JC . ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 2014; 111: 1951\u20131956.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017461_CR51","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/JVI.01967-10","volume":"85","author":"Y Yu","year":"2011","unstructured":"Yu Y, Maguire TG, Alwine JC . Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection. J Virol 2011; 85: 1573\u20131580.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR52","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/JVI.73.4.2825-2831.1999","volume":"73","author":"DM Lukac","year":"1999","unstructured":"Lukac DM, Alwine JC . Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells. J Virol 1999; 73: 2825\u20132831.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR53","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/sj.onc.1206503","volume":"22","author":"T Panaretakis","year":"2003","unstructured":"Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D . Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 2003; 22: 4543\u20134556.","journal-title":"Oncogene"},{"key":"BFcddis2017461_CR54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/rmv.1836","volume":"25","author":"P Kumari","year":"2015","unstructured":"Kumari P, Narayanan S, Kumar H . Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways. Rev Med Virol 2015; 25: 187\u2013201.","journal-title":"Rev Med Virol"},{"key":"BFcddis2017461_CR55","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.1534570100","volume":"100","author":"EP Browne","year":"2003","unstructured":"Browne EP, Shenk T . Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci USA 2003; 100: 11439\u201311444.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017461_CR56","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0300060513483398","volume":"41","author":"ZZ Lai","year":"2013","unstructured":"Lai ZZ, Ni Z, Pan XL, Song L . Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer. J Int Med Res 2013; 41: 1027\u20131036.","journal-title":"J Int Med Res"},{"key":"BFcddis2017461_CR57","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/JVI.02406-09","volume":"84","author":"MA Clementz","year":"2010","unstructured":"Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, Ratia K et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 2010; 84: 4619\u20134629.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR58","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.1128\/JVI.00690-11","volume":"85","author":"KS Inn","year":"2011","unstructured":"Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K et al. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J Virol 2011; 85: 10899\u201310904.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR59","doi-asserted-by":"crossref","unstructured":"Kumari P, Kumar H. Viral deubiquitinases: role in evasion of anti-viral innate immunity. Crit Rev Microbiol 2017 (doi:10.1080\/1040841X.2017.1368999).","DOI":"10.1080\/1040841X.2017.1368999"},{"key":"BFcddis2017461_CR60","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1128\/JVI.02020-12","volume":"87","author":"S Saito","year":"2013","unstructured":"Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A et al. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication. J Virol 2013; 87: 4060\u20134070.","journal-title":"J Virol"},{"key":"BFcddis2017461_CR61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbbm.2005.08.001","volume":"64","author":"C Zou","year":"2005","unstructured":"Zou C, Wang Y, Shen Z . 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods 2005; 64: 207\u2013215.","journal-title":"J Biochem Biophys Methods"},{"key":"BFcddis2017461_CR62","doi-asserted-by":"crossref","first-page":"e1000332","DOI":"10.1371\/journal.ppat.1000332","volume":"5","author":"N Sathish","year":"2009","unstructured":"Sathish N, Zhu FX, Yuan Y . Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules. PLoS Pathog 2009; 5: e1000332.","journal-title":"PLoS Pathog"},{"key":"BFcddis2017461_CR63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-014-0506-7","volume":"17","author":"HJ Choi","year":"2015","unstructured":"Choi HJ, Lui A, Ogony J, Jan R, Sims PJ, Lewis-Wambi J . Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death. Breast Cancer Res 2015; 17: 6.","journal-title":"Breast Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017461","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:48:51Z","timestamp":1671734931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"alternative-id":["BFcddis2017461"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.461","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]},"assertion":[{"value":"21 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}